AN EVALUATION OF THE CLINICAL RELEVANCE OF DRUG-DRUG INTERACTIONS IN THE INTENSIVE CARE SETTING

被引：0
|
作者：
Newsome, Andrea [1 ]
Hsia, Bernard [1 ]
机构：
[1] UGA, Augusta, SC USA
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
948
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Drug-drug interactions contributing to QT prolongation in cardiac intensive care units
    Armahizer, Michael J.
    Seybert, Amy L.
    Smithburger, Pamela L.
    Kane-Gill, Sandra L.
    [J]. JOURNAL OF CRITICAL CARE, 2013, 28 (03) : 243 - 249
  • [32] Corrected QT interval for possible drug-drug interactions in the intensive care unit
    Armahizer, Michael J.
    Seybert, Amy L.
    Smithburger, Pamela L.
    Kane-Gill, Sandra L.
    [J]. JOURNAL OF CRITICAL CARE, 2013, 28 (06) : 1107 - 1107
  • [33] Drug-drug interactions in Neonatal Intensive Care Units: how to overcome a challenge
    Rosen, Kai
    Wiesen, Martin H.
    Oberthuer, Andre
    Michels, Guido
    Roth, Bernd
    Fietz, Cornelia
    Mueller, Carsten
    [J]. MINERVA PEDIATRICS, 2021, 73 (02): : 188 - 197
  • [34] Drug-drug interactions in an intensive care unit and comparison of updates in two databases
    Riera, Pau
    Sole, Nuria
    Carlos Suarez, Juan
    Andrea Lopez, Paula
    Fonts, Nuria
    Rodriguez-Farre, Nuria
    Fernandez de Gamarra-Martinez, Edurne
    Moran, Indalecio
    [J]. FARMACIA HOSPITALARIA, 2022, 46 (05) : 290 - 295
  • [35] Risk factors for potential drug-drug interactions in intensive care unit patients
    Jankovic, Slobodan M.
    Pejcic, Ana V.
    Milosavljevic, Milos N.
    Opancina, Valentina D.
    Pesic, Nikola V.
    Nedeljkovic, Tamara T.
    Babic, Goran M.
    [J]. JOURNAL OF CRITICAL CARE, 2018, 43 : 1 - 6
  • [36] Analysis of Potential Drug-Drug Interactions in Medical Intensive Care Unit Patients
    Uijtendaal, Esther V.
    van Harssel, Lieke L. M.
    Hugenholtz, Gerard W. K.
    Kuck, Emile M.
    Zwart-van Rijkom, Jeannette E. F.
    Cremer, Olaf L.
    Egberts, Toine C. G.
    [J]. PHARMACOTHERAPY, 2014, 34 (03): : 213 - 219
  • [37] Prevalence of potential drug-drug interactions requiring biomarkers for the assessment of clinical relevance
    Geerts, Arjen
    de Koning, Fred H. P.
    de Smet, Peter A. G.
    van Solinge, Wouter W.
    Egberts, Toine C. G.
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 251 - 252
  • [38] Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
    Hulskotte, L.
    Topfer, W.
    Reyners, A. K. L.
    Taxis, K.
    Jansman, F.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1084 - S1084
  • [39] Thienopyridine-associated drug-drug interactions: Pharmacologic mechanisms and clinical relevance
    Hulot J.-S.
    Collet J.-P.
    Montalescot G.
    [J]. Current Cardiology Reports, 2011, 13 (5) : 451 - 458
  • [40] Identifying potential drug-drug interactions in the intensive care unit: Source matters!
    Vanham, D.
    Hantson, P.
    Wittebole, X.
    Spinewine, A.
    Sneyers, B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1283 - 1284
12345